11 results
inhibitors management summary agonists diagnosis dosing dpp4 glp1 insulin medications table acromegaly analogs disorders duration graph inpatient ketones ketosis mellitus
The graph illustrates the differences in the onset and duration of action for various types of
glulisine), Regular, NPH ... Detemir, Glargine #Diabetes ... Timeline #Graph #Comparison ... #Pharmacology # ... Endocrinology
Insulin Comparison Chart Insulin Types - Onset (hours) - Peak Glycemic Effect (hours) - Duration (hours) •
Insulin Comparison ... Protamine + Lispro, NPH ... 10 #Insulin #Comparison ... #Table #pharmacology ... #diabetes #endocrinology
Diabetes Mellitus Type 2 Inpatient Medication Guide Classes: Biguanide, Sulfonylurea, TZD, DPP-4 inhibitor, GLP-1 receptor agonist, SGLT2i,
mealtime • If NPO ... #Mellitus #DM2 ... #Medications #pharmacology ... #comparison #table ... #endocrinology
Metformin Pharmacology Summary Mechanisms of Action: • Suppresses gluconeogenesis by the liver • Increases insulin-mediated glucose utilization
Metformin Pharmacology ... agent • Does not cause ... #Metformin #Pharmacology ... #Summary #DM2 # ... diabetes #endocrinology
SGLT2 Inhibitors SGLT2 inhibitors are the newest class of anti-diabetic medications, with the first one (Canagliflozin)
These work by inhibiting ... kidney), which causes ... SGLT2 #Inhibitors #Pharmacology ... #Medications #DM2 ... #Diabetes #Endocrinology
GLP-1 Agonists Adlyxin (Lixisenatide) Daily Bydureon (Exenatide ER) Weekly Ozempic (Semaglutide) Weekly Trulicity (Dulaglutide) Weekly Victoza (Liraglutide) Daily
to treat Type 2 Diabetes ... They work primarily ... GLP1 #Agonists #Pharmacology ... #Dosing #Diabetes ... #DM2 #Endocrinology
GLP-1 Receptor Agonists - Pharmacology Summary Mechanisms of Action: Stimulate glucose-dependent insulin release from the pancreas (GLP-1
Receptor Agonists - Pharmacology ... not definitively cause ... Receptor #Agonists #Pharmacology ... #Summary #DM2 # ... diabetes #endocrinology
DPP-4 Inhibitors - Pharmacology Summary Mechanisms of Action: Inhibits DPP-4 (dipeptidyl peptidase 4), which normally inactivates GLP-1
4 Inhibitors - Pharmacology ... not definitively cause ... DPP4 #Inhibitors #Pharmacology ... #Summary #DM2 # ... diabetes #endocrinology
DPP4 Inhibitors - Normal and Renal Dosing Increase Incretins (GLP-I & GIP) -> Stimulates Insulin, Inhibits Glucagon
DPP4 inhibitors work ... Renal #Dosing #Pharmacology ... #Management #Diabetes ... #DM2 #Endocrinology
Ketosis Disorders Ketone bodies are a normal metabolic energy source. Excessive unregulated production of ketones, often accompanied
• Diabetic ketoacidosis ... (DKA) - caused ... gap acidosis (pH ... Disorders #ketones #differential ... diagnosis #management #endocrinology
No results found for "NPH endocrinology diabetes differential workup causes pharmacology dm2 comparison"
Try removing search terms or sorting by relevance
Or Upload an image for you and others searching for #NPH #endocrinology #diabetes #differential #workup #causes #pharmacology #dm2 #comparison